← All Signals

🏥 FDA: Agebox — Class II

healthcareactionableSource: FDA
95%Confidence
0Views
FDASource
2026-03-10Date

Summary

Agebox recalls children's growth product for containing undeclared ibutamoren (a growth hormone secretagogue) without FDA approval, a Class II violation. This raises serious safety concerns about unapproved drug ingredients in consumer supplements.

Actionable: Immediately discontinue use of Agebox iKids-Growth and report adverse events to FDA, as undeclared pharmaceuticals pose significant health risks to children.

AI Confidence: 95%

Data Points

firmAgebox
classificationClass II
statusOngoing
distributionThe product was distributed nationwide in the U.S. Agebox sells its U.S. products through Agebox.com (using Shopify) and Amazon.com. All orders are shipped to customers by Agebox itself; other parties are not involved in the distribution of the physical product.
productAgebox iKids-Growth (Night Formula), 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 850065597027

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now